Search

Your search keyword '"Pongas, Georgios"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Pongas, Georgios" Remove constraint Author: "Pongas, Georgios" Database MEDLINE Remove constraint Database: MEDLINE
24 results on '"Pongas, Georgios"'

Search Results

1. Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.

2. Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations.

3. Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies.

4. Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case.

5. Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.

6. Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma.

7. Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia.

8. HIV-Associated Lymphomas: Progress and New Challenges.

10. Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

11. Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma.

12. Mantle cell lymphoma involving the thyroid gland.

13. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.

14. Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study.

15. PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma.

16. BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1).

17. PI3K signaling pathway in normal B cells and indolent B-cell malignancies.

18. BEZ235: When Promising Science Meets Clinical Reality.

19. Identification of therapeutic targets applicable to clinical strategies in ovarian cancer.

20. Antiplatelet factor 4/heparin antibodies in patients with gram negative bacteremia.

22. Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study.

23. Activity of deferasirox in Mucorales: influences of species and exogenous iron.

Catalog

Books, media, physical & digital resources